about
Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.Evaluation of virtual touch tissue imaging quantification, a new shear wave velocity imaging method, for breast lesion assessment by ultrasound.LECANDUS study (LEsion CANdidate Detection in UltraSound Data): evaluation of image analysis algorithms for breast lesion detection in volume ultrasound data.Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer.Plasma microRNA panel for minimally invasive detection of breast cancerDetected, yet not Diagnosed - Breast Cancer Screening with MRI Mammography in High-Risk Women.Extent of primary breast cancer surgery: standards and individualized concepts9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium.Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade.Women at familial risk of breast cancer electing for prophylactic mastectomy: frequencies, procedures, and decision-making characteristics.Long-term experiences with genetic consultation in people with hereditary breast and ovarian cancer.Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.Inter-rater reliability and double reading analysis of an automated three-dimensional breast ultrasound system: comparison of two independent examiners.Upper Blepharoplasty for Areola Reconstruction.Ultrasound-guided cryoablation of breast fibroadenoma: a pilot trial.Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.Analysis of the distribution shift of detected aneuploidies by age independent first trimester screening.Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit.Breast cancer mastectomy trends between 2006 and 2010: association with magnetic resonance imaging, immediate breast reconstruction, and hospital volume.Ultrasound guided cryoablation of fibroadenomas.Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis.Oncotype DX® in breast cancer patients: clinical experience, outcome and follow-up-a case-control study.Quality of life and anxiety of patients affected by the PIP/Rofil Medical breast implant recall: results from a prospective monocentre cohort study.Change of Patient-Reported Aesthetic Outcome Over Time and Identification of Factors Characterizing Poor Aesthetic Outcome After Breast-Conserving Therapy: Long-Term Results of a Prospective Cohort Study.Predictors of early poor aesthetic outcome after breast-conserving surgery in patients with breast cancer: initial results of a prospective cohort study at a single institution.Objective assessment of aesthetic outcome after breast conserving therapy: subjective third party panel rating and objective BCCT.core software evaluation.Change of aesthetic and functional outcome over time and their relationship to quality of life after breast conserving therapy.Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?Development and psychometric validation of a shorter version of the Breast Cancer Treatment Outcome Scale (BCTOS-12).Is Mastectomy Oncologically Safer than Breast-Conserving Treatment in Early Breast Cancer?Dedicated computer-aided detection software for automated 3D breast ultrasound; an efficient tool for the radiologist in supplemental screening of women with dense breasts.Vacuum-Assisted Biopsy to Diagnose a Pathological Complete Response in Breast Cancer Patients After Neoadjuvant Systemic Therapy.Implementation of a novel efficacy score to compare sealing and cutting devices in a porcine model.Detection and Removal of Ceramic Clip Markers from Breast Tissue by Ultrasound-Guided, Vacuum-Assisted Minimally Invasive Biopsy in a Turkey Breast Model.Interobserver reliability of automated breast volume scanner (ABVS) interpretation and agreement of ABVS findings with hand held breast ultrasound (HHUS), mammography and pathology results.Preliminary analysis of the new 'Prenatal Risk Calculation (PRC)' software.Aesthetic and functional results after breast conserving surgery as correlates of quality of life measured by a German version of the Breast Cancer Treatment Outcome Scale (BCTOS).Aesthetics in breast conserving therapy: do objectively measured results match patients' evaluations?Do Patients After Reexcision Due to Involved or Close Margins Have the Same Risk of Local Recurrence as Those After One-Step Breast-Conserving Surgery?Recall management of patients with Rofil Medical breast implants.
P50
Q30361333-EC22621D-0048-46A0-820E-C3FAB02DFE1CQ30438892-F1BF73D7-6306-4113-B248-D303D0BD8642Q31103508-3138F784-05A5-4584-9C7E-0D967BC7C149Q33411565-E7BF0D64-7A38-44BC-A779-8BC7B34BF69CQ35032320-CE55601D-F141-4DB5-854D-92C8940120A3Q36131376-BF3014D9-F7A7-4BAE-99A6-7B48C3755888Q36457859-F8055834-6254-48B2-8B58-4C69B8AB3E6CQ37169873-1634D995-2AF7-4605-8470-022E2CE82A0BQ37385681-78C6909B-8E64-4076-ABE8-1DE87B4349C2Q38821731-DC117BD1-F23A-415B-A292-602291B9E5ABQ39695669-CBD5696F-315E-46F4-A76A-353D94987BD5Q39934142-A09A859A-FD12-40F6-8379-1E058C3C7122Q40106637-F59C5B31-4655-4B2A-BE74-C92FE65F13F7Q41786390-EA212325-1C61-474C-9D40-C5994CCA7934Q43612390-DA1288F0-8521-4BA2-9712-5F97946CB9BDQ43904894-47BFBE72-55F5-403B-9C0A-26A4B9A7B7B4Q44153965-F2170521-A32F-41F7-9AB4-0AB357AC7A1AQ45905465-7538D312-D2F2-4FB0-9E6D-B890F23F00A5Q45995803-5B534D67-D235-412F-BACD-94DE5C625FE0Q46551468-6AAD4674-4E87-4646-9516-5D2AA1EF55E7Q47199555-5B279162-381D-4BC9-A7E9-921B5B401153Q47318209-4A3038A8-E51C-4BC3-A4FC-4A2DC8A177C2Q47856445-CF17E3CD-FEE4-49ED-92FD-4E8DF40D2339Q47917275-7C47E3FB-0F71-4261-8EC0-A834A5AAB2EBQ48067945-46168EA5-1922-48F0-8791-169C3D84AF0CQ48608760-DCFB64BF-E070-438B-AD54-633264D33AF0Q48737621-F6D5B52F-27E8-4DCA-87D7-30EABAB22096Q49634019-D48E1ECA-F621-4611-AF65-C868BC309F28Q49719784-50854839-2E8C-45A5-B7BF-5A10029F1247Q49885178-266BBC65-D2F7-4B38-AB66-48C43065AB71Q50054517-5984B60A-3395-4CFA-BFC4-F1B184D9E3E7Q50076331-50556C6D-CB2D-4599-ABB6-BD02B2759989Q50495914-7EF96C81-B7FB-45C6-BA66-73A373FE1FA1Q51148851-FCDF1A3E-1043-4531-86FF-52C418C3BC7BQ51238652-456D22F6-4C36-48D0-A56A-922ECC7B431CQ51871202-F49205F7-6E71-4CEE-9CE5-C60CB098D24AQ53068698-078E973F-39C4-4D4D-B991-1A4422491D79Q53072238-386495AC-9998-4134-A08A-A193190D806BQ53220263-FE51C6FA-385D-434C-9C41-F1BA68CB5763Q53562023-B3C1A75D-31F9-42FF-8F65-A32E75FF3A6A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael Golatta
@ast
Michael Golatta
@de
Michael Golatta
@en
Michael Golatta
@es
Michael Golatta
@nl
Michael Golatta
@sl
type
label
Michael Golatta
@ast
Michael Golatta
@de
Michael Golatta
@en
Michael Golatta
@es
Michael Golatta
@nl
Michael Golatta
@sl
prefLabel
Michael Golatta
@ast
Michael Golatta
@de
Michael Golatta
@en
Michael Golatta
@es
Michael Golatta
@nl
Michael Golatta
@sl
P106
P21
P31
P3835
michael-golatta
P496
0000-0002-2605-0060
P569
2000-01-01T00:00:00Z